[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:pyoderma-gangrenosum":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"Pyoderma gangrenosum",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06563323","Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)",[11],"Phase 2","RECRUITING","2026-08-26T02:18:35.425468Z","2026-05-05T02:43:27.965076Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06624670","A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum",[19],"Phase 3","2026-08-26T02:19:15.498463Z","2026-05-05T02:43:27.945704Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT02280733","A Real-World Registry of Chronic Wounds and Ulcers",[],"2026-08-26T02:18:09.641312Z","2026-05-13T02:55:06.094374Z",[],[]]